What AI says about ConcertAI Clinical Trial Optimization

ConcertAI's Clinical Trial Optimization for Hematology (CTO-H) is a software-as-a-service platform for research analytics, trial design, and operational optimization in hematologic malignancies, leveraging real-world data and AI. It provides real-time feasibility, site selection, and protocol refinement to accelerate enrollment, reduce site footprint, and preempt endpoint failures and eligibility gaps. It also improves diversity and equity by identifying diverse geographies and underserved populations, helping preempt amendments through early feasibility modeling.